Mr. Mark Forney reports

DELPHX GRANTS STOCK OPTIONS

Delphx Capital Markets Inc.'s board of directors has approved the grant of 1.1 million stock options to eligible participants under its stock option plan. The options have a two-year maturity and are exercisable for common shares of Delphx at an exercise price of 20 cents per common share, all in accordance with the plan.

About Delphx Capital Markets Inc.

Delphx is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the company enables fixed-income dealers to offer new private placement securities that optimally transfer and diffuse credit risk, while allowing the enhancement of yield. The new Delphx securities enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured default protection or rating downgrade protection for underlying corporate, municipal and sovereign securities;
• Collateralized reference notes (CRNs) that enable credit investors to take on the default or rating downgrade exposure of an underlying security in exchange for enhanced yield.

All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are provisionally patent- and intellectual property-protected proprietary products created and owned by Delphx Capital Markets.

We seek Safe Harbor.